SUPRIYANSESupriya Lifescience LimitedMinimalNeutral
Announced Thu, 28 May · 15:52 IST

Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+29.4%1-day move
₹811.00
prior close
₹887.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.3+3.6+3.7+6.1+29.4+12.7+11.2+17.6+16.5+18.5+14.9+19.4
Up moveDown movePending
AI summary

Supriya Lifescience has published newspaper advertisements (Financial Express and Loksatta) containing extracts of audited financial results for the quarter and year ended March 31, 2026, as required under SEBI LODR Regulations. Total Income for FY2026 stood at Rs. 56,750 Lakhs compared to Rs. 54,734 Lakhs in FY2025, showing ~3.7% growth. Profit Before Tax increased to Rs. 8,549 Lakhs from Rs. 7,074 Lakhs (20.8% YoY growth), while Profit After Tax grew to Rs. 6,892 Lakhs from Rs. 5,680 Lakhs (21.3% YoY growth). EPS for the year improved significantly to Rs. 36.07 from Rs. 31.88. The results were considered by the Board on May 26, 2026, and published on May 28, 2026.

Likely market impact

Strong improvement in profitability with PAT growing over 21% YoY indicates operational efficiency gains. Higher EPS and maintained dividend suggest positive sentiment for shareholders, likely supporting the stock price.